OBJECTIVE: The aim of this study was to evaluate the safety and efficiency of enucleation (EU) for proximal pancreatic non-invasive neoplasms. METHODS: Patients with solitary non-invasive neoplasms in the proximal pancreas from January 1998 to April 2014 at the Second Affiliated Hospital of Zhejiang University, Hangzhou, China were included. Different operations and outcomes were analyzed. RESULTS: A total of 123 patients were enrolled. Forty patients (32.5%) underwent EU including 18 patients who had tumors close to the main pancreatic duct (MPD). Sixty-one patients (49.6%) had pancreaticoduodenectomy (PD) performed and 22 (17.9%) underwent central pancreatectomy (CP). Pathological outcomes included neuroendocrine tumors, cystic lesions, and solid pseudopapillary tumors. Operation time, intra-operative blood loss, and duration of hospital stay were significantly reduced in the EU group. PD was associated with the greatest complication rate (55.7%), followed by EU (50%) and CP (40.9%), though the pancreatic fistula rate after EU was the highest (50%), especially in patients with tumors larger than 3 cm and tumors close to the MPD. EU had advantages in the preservation of pancreatic parenchyma and endocrine and exocrine function. CONCLUSIONS: EU can be carried out safely and effectively for tumors in the proximal pancreas with improved outcomes compared with standard resections, even if the tumor is larger than 3 cm and close to the MPD.
OBJECTIVE: The aim of this study was to evaluate the safety and efficiency of enucleation (EU) for proximal pancreatic non-invasive neoplasms. METHODS:Patients with solitary non-invasive neoplasms in the proximal pancreas from January 1998 to April 2014 at the Second Affiliated Hospital of Zhejiang University, Hangzhou, China were included. Different operations and outcomes were analyzed. RESULTS: A total of 123 patients were enrolled. Forty patients (32.5%) underwent EU including 18 patients who had tumors close to the main pancreatic duct (MPD). Sixty-one patients (49.6%) had pancreaticoduodenectomy (PD) performed and 22 (17.9%) underwent central pancreatectomy (CP). Pathological outcomes included neuroendocrine tumors, cystic lesions, and solid pseudopapillary tumors. Operation time, intra-operative blood loss, and duration of hospital stay were significantly reduced in the EU group. PD was associated with the greatest complication rate (55.7%), followed by EU (50%) and CP (40.9%), though the pancreatic fistula rate after EU was the highest (50%), especially in patients with tumors larger than 3 cm and tumors close to the MPD. EU had advantages in the preservation of pancreatic parenchyma and endocrine and exocrine function. CONCLUSIONS: EU can be carried out safely and effectively for tumors in the proximal pancreas with improved outcomes compared with standard resections, even if the tumor is larger than 3 cm and close to the MPD.
Entities:
Keywords:
Enucleation; Pancreatic fistula; Pancreaticoduodenectomy; Central pancreatectomy
Authors: Suzanne M Inchauste; Brock J Lanier; Steven K Libutti; Giao Q Phan; Naris Nilubol; Seth M Steinberg; Electron Kebebew; Marybeth S Hughes Journal: World J Surg Date: 2012-07 Impact factor: 3.352
Authors: C E Cauley; H A Pitt; K M Ziegler; A Nakeeb; C M Schmidt; N J Zyromski; M G House; K D Lillemoe Journal: J Gastrointest Surg Date: 2012-04-24 Impact factor: 3.452
Authors: Olivier Turrini; C Max Schmidt; Henry A Pitt; Jerome Guiramand; Juan R Aguilar-Saavedra; Shadi Aboudi; Keith D Lillemoe; Jean Robert Delpero Journal: HPB (Oxford) Date: 2011-02 Impact factor: 3.647
Authors: Kaye M Reid-Lombardo; Antonio Ramos-De la Medina; Kristine Thomsen; William S Harmsen; Michael B Farnell Journal: J Gastrointest Surg Date: 2007-10-11 Impact factor: 3.452